GL1X · GenesisL1 explorer

MolNFT v1 · #187263 · protein

Structure of the SARS-cov-2 main protease in complex with inhibitor MPI36

7S72 · 3C-like proteinase: “Structure of the SARS-cov-2 main protease in complex with inhibitor MPI36”. X-ray diffraction, 1 ligand (8I0), 2 pockets (best druggability 0.42). MolNFT v1 #187263 on GenesisL1: 3D structure, binding sites and…

PDB
7S72
Type
protein
Length
300 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
8I0
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein30024% helix, 29% strandP0DTD1

Ligands and binding sites

  • 8I0 · (1R,2S,5S)-N-{(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11370.420.7529empty
2940.330.74198I0

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7S72 · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI36 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.